Biomarker Technologies Corporation (BMKGENE) is a renowned brand in the field of genomics services. Founded in 2009 and headquartered in Beijing, China, BMKGENE has been at the forefront of innovation and development in high-throughput sequencing technologies and bioinformatics for over 14 years. With a global presence in over 50 regions, BMKGENE collaborates with universities, hospitals, research institutes, pharmaceutical companies, and more.

BMKGENE's main business consists of science and technology services, offering a wide range of comprehensive high-throughput biological measurements and bioinformatics services. These services cover various areas including genomics, transcriptomics, epigenetics, single-cell omics, proteomics, and metabolomics. In addition to their services, BMKGENE provides an online bioinformatics platform, which offers efficient and user-friendly tools for bioinformatics analysis.

With a highly-skilled R&D team, extensive patent portfolio, and exceptional technical expertise, Biomarker Technologies is dedicated to creating innovative biotechnology solutions and establishing itself as a symbol of excellence in the bio-industry. Through their state-of-the-art sequencing platforms and advanced computing platforms, BMKGENE aims to benefit humanity and lead the way in genetic technology